Avian intestinal spirochaetosis (AIS) is a disease complex affecting adult laying and breeding chickens associated with infection by anaerobic intestinal spirochaetes of the genus Brachyspira.
Introduction
Avian intestinal spirochaetosis (AIS) is a disease complex associated with colonization of adult chickens or other poultry species by pathogenic intestinal spirochaetes of the genus Brachyspira (formerly Serpulina) , Stephens and Hampson, 2001 and Hampson and Swayne, 2008 . AIS most commonly has been reported in flocks of laying hens and broiler breeders where it has been associated with a variety of non-specific clinical signs and production problems.
Reported examples of problems include pasty vents, wet litter, faecal staining of eggshells, increased fat content of faeces, delayed onset of egg laying, reduced egg production, increased mortalities, and a reduced feed conversion ratio ( Devalaar et al., 1986 , Griffiths et al., 1987 , Dwars et al., 1989 , Swayne et al., 1992 , Swayne et al., 1995 , Trampel et al., 1994 , Hampson and McLaren, 1999 , Stephens and Hampson, 2001 , Burch et al., 2006 and Bano et al., 2008 . Broiler flocks derived from infected breeders may show poor feed conversion ratios, a high number of weak chicks, slow growth, and poor feed digestion ( Dwars et al., 1993 and Smith et al., 1998) .
Infections with the pathogenic species B. intermedia, B. pilosicoli, B. alvinipulli, and B. hyodysenteriae have all been reported in chickens, with B. intermedia usually being most consistently and commonly encountered in epidemiological surveys of flocks with AIS , Stephens and Hampson, 1999 , Stephens et al., 2005 , Bano et al., 2008 , Feberwee et al., 2008 and Jansson et al., 2008 .
Infections with Brachyspira species in pigs are routinely controlled using antimicrobial agents, but there are few antimicrobials available that are registered for use in laying chickens, and this makes control of AIS difficult. Implementing good shed hygiene and strict biosecurity measures can be used to try to prevent infection being introduced into flocks (Phillips et al., 2003) , but this strategy is not always successful. To date there are no commercial vaccines available to help prevent or control AIS.
The aim of the current work was to undertake a pilot study to determine whether vaccination with an autogenous bacterin could confer protection against AIS caused by B. intermedia in laying chickens.
Materials and methods

Permissions
The experimental work was conducted with the approval of the Murdoch University Animals Ethics Committee.
Spirochaete growth
B. intermedia strain HB60, originally isolated from a chicken in a Western Australian layer flock with a wet litter problem, was obtained as frozen stock from the culture collection held at the Australian Reference Centre for Intestine Spirochaetes, School of Veterinary and Biomedical Sciences, Murdoch University. The cells were thawed, and grown at 37 °C in Kunkle's pre-reduced anaerobic broth containing 2% (v/v) foetal bovine serum and 1% (v/v) ethanolic cholesterol solution (Kunkle et al., 1986) . The spirochaetes were harvested in early log-phase, when they were actively motile.
Spirochaete growth and absence of contamination were monitored by examining aliquots under a phase contrast microscope.
Bacterin vaccine
The spirochaete cells were harvested by centrifugation, washed three times in sterile phosphate buffered saline (PBS), pH 7.2, resuspended in PBS and inactivated by addition of 0.4% formalin followed by stirring overnight at 4 °C. The spirochaetes were counted in a haemocytometer chamber under a phase contrast microscope, adjusted to 10 10 cells/ml, aliquoted and stored at −20 °C.
Immediately before administration the bacterin was thawed and sonicated in a commercial water-inoil adjuvant (Emulsigen; MUP Laboratories Inc., Ralston, USA) to produce an emulsion.
Serum samples
The chickens were bled from the marginal wing vein four times during the course of the experiment, commencing immediately prior to the first vaccination (pre-vaccination), immediately prior to the second vaccination (pre-boost), immediately prior to the experimental challenge (pre-infection) and at post-mortem. The blood was held at 4 °C overnight and the serum was removed, divided into aliquots and stored at −20 °C. Immediately prior to use the sera were thawed on ice and briefly vortexed.
ELISA
Whole cells of B. intermedia HB60 (10 8 ml −1 in PBS) were sonicated on ice using three cycles of 30 s with 2 min between cycles. The sonicate was centrifuged at 10,000 × g for 10 min and the supernatant used as plate coating antigen stock. Total protein content was determined using a commercial dyebinding assay kit (Bio-Rad Laboratories, Hercules, CA, USA), then the sonicate was diluted in bicarbonate/carbonate coating buffer (pH 9.6) to a working dilution of 2 μg total protein/ml. 100 μl of 
Spirochaete isolation and PCR
Bacteriology swabs were used to collect discrete samples of fresh faeces from the cage floor of each chicken, and also to swab the mucosal surface of the caecal walls and rectum at post-mortem. The swabs were used to inoculate selective agar plates (Jenkinson and Wingar, 1981) , consisting of Trypticase Soy agar (BBL, Cockeysville, USA) containing 5% (v/v) defibrinated sheep blood, 400 μg/ml spectinomycin and 25 μg/ml each of colistin and vancomycin (Sigma-Aldrich). The plates were incubated for 5-7 days at 37 °C in a jar with an anaerobic environment generated using a GasPak Plus™ disposable hydrogen plus carbon dioxide generator envelope with a palladium catalyst (Becton Dickinson Microbiology Systems). The presence of low flat spreading growth of spirochaetes on the plate was recorded. The suspected areas of spirochaete growth were resuspended in PBS, and examined under a phase contrast microscope at 400× magnification. Spirochaetal growth was collected from the surface of the plate using a wooden toothpick, resuspended in ultra-pure water and used as a template for B. intermedia PCR amplification, as previously described .
Experimental protocol
Twenty-four ISA-Brown laying chickens of 20 weeks of age were purchased from a commercial breeder and housed in individual cages with mesh floors located in a room in an environmentally controlled (22-25 °C) facility. The chickens were subjected to 12 h artificial light each day. They were fed ad libitum on a commercial mash formulated to meet the nutritional requirements of laying chickens, and water was available to them ad libitum. Twelve of the chickens were vaccinated with the bacterin and the other 12 chickens were left unvaccinated. The cages were arranged so that each alternate cage contained a vaccinated chicken.
One week after arrival, at 21 weeks of age, the chickens were vaccinated with 1 ml of the bacterin vaccine by injection into the pectoral muscles. They were vaccinated again 3 weeks later, at 24 weeks of age.
The chickens were weighed on entry to the experiment and at weekly intervals thereafter. Eggs were collected daily and weighed. At weekly intervals aluminum foil was placed under the cage of each chicken, and after 1-h individual caecal faeces samples were collected. Approximately 2 g of the samples were weighed, and then dried to constant weight in a hot air oven to determine their moisture content.
Faeces were collected from all chickens prior to experimental infection, and then every 2-3 days until the end of the experiment. For each subgroup a total of 180 excreta samples were obtained at 15 sampling times over the 5-week post-infection period.
Experimental infection
Experimental infection commenced 2 weeks after the second vaccination, when the chickens were 26 weeks of age, and all were laying eggs. The chickens were orally inoculated via a crop tube with 4 ml of the appropriate actively growing culture, on 4 consecutive days. The broths contained approximately 10 8 to 10 9 motile bacterial cells/ml.
Post-mortem examination
Six weeks after the experimental challenge (at 32 weeks of age) the chickens were killed by cervical dislocation, and subjected to post-mortem examination. The caecum and rectum were opened to look for evidence of gross changes. A section of one caecum was placed in 10% neutral buffered formalin as a fixative for subsequent histological examination, and swabs were taken from the wall of the other caecum and the rectum for spirochaete culture. These were processed as for faecal samples. The fixed tissue was processed through to paraffin blocks, sectioned at 4 μm and stained with haematoxylin and eosin and with the Warthin-Starry silver stain.
Analysis of data
Comparisons were made between the two groups of chickens using InStat version 3 (Graphpad Software, San Diego, CA, USA). The ratio of the total number of faecal samples collected that were positive and negative for B. intermedia were compared between the vaccinated and non-vaccinated groups using Chi-squared tests. Weekly weights, faecal moisture content, egg numbers, and egg weights were compared using one-way analysis of variance. Means were compared using the TukeyKramer multiple comparisons test, with significance accepted at the 5% level.
Results
Antibody levels
Vaccinated chickens showed a significant (P < 0.05) primary antibody response following the first vaccination (Fig. 1) . The mean antibody level increased following the second vaccination, but this increase just failed to reach statistical significance. The antibody level then showed a significant (P < 0.01) reduction at post-mortem, with 10 of the 12 vaccinated chickens showing reductions in antibody levels. In comparison, the non-vaccinated chickens only showed a significant (P < 0.001) increase in antibody levels following experimental infection.
Colonization
None of the chickens were positive for intestinal spirochaetes prior to experimental infection.
Following experimental challenge, all chickens excreted spirochaetes in their faeces at some point (range 1-13 samplings positive). Of the 180 faecal samples that were collected over the post-infection period, 82 (45.6.%) were B. intermedia positive for the vaccinated chickens and 80 (44.4%) were positive for the unvaccinated chickens. These differences were not statistically significant. At postmortem B. intermedia was isolated from the caecum and/or rectum of 8 vaccinated chickens and from 11 of the non-vaccinated chickens. Again these differences were not significant.
Faecal water content
Within each group the faecal water content of the chickens did not change significantly with time (Table 1) , and pair-wise comparisons between the vaccinated and non-vaccinated chickens were not significantly different at any sampling time.
Chicken weights, egg numbers, and egg weights
No significant differences were found between the vaccinated and non-vaccinated chickens in weekly body weights, weekly egg weights, or weekly egg numbers (data not shown).
Post-mortem findings
At post-mortem chickens from both groups had enlarged ballooning caeca with frothy and mucoid contents. No gross pathological lesions were observed. Histologically all sections showed variable oedema and congestion of the lamina propria, and some sections showed localized areas of separation of the epithelium from the underlying lamina. Bacteria with the appearance of spirochaetes were seen in the crypts and adjacent to the luminal epithelium in all sections, with spirochaete-like forms seen in the lamina propria just under the epithelium in occasional sections. There were no consistent differences between the two groups of chickens in the appearances of the sections or in the number or disposition of the spirochaete-like bacteria that were observed.
Discussion
B. intermedia strain HB60 previously has been used to experimentally infect laying chickens ( Hampson and McLaren, 1999 , Hampson et al., 2002 ). In the current study this strain colonized the chickens, and the control chickens developed antibodies to whole cell extracts of the B. intermedia strain following experimental challenge. Unlike previous studies, the colonization was not associated with any obvious clinical signs such as reduced egg production and increased faecal water content, although there were abnormalities of the caecal contents and microscopic changes in the caeca. Whilst vaccination did result in elevated serum antibody levels to HB60, there was no evidence that this influenced colonization or reduced the mild pathological changes found in the caeca following experimental infection. Hence it appears that bacterin vaccines are unlikely to be particularly useful in preventing AIS caused by B. intermedia.
Previously, bacterin vaccines against B. hyodysenteriae have been reported to offer variable and generally incomplete protection against swine dysentery in pigs ( Fernie et al., 1983 , Hampson et al., 1993 , Diego et al., 1995 and Waters et al., 1999 , whilst a bacterin against B. pilosicoli did not prevent colonization with this spirochaete in experimentally infected pigs (Hampson et al., 2000) . Hence the failure of the current bacterin to offer protection in laying chickens is not altogether surprising. More recently the use of a swine dysentery vaccine based on a recombinant 29.7 kDa outer membrane lipoprotein (Bhlp29.7) of B. hyodysenteriae did provide a degree of protection to experimentally infected pigs . Hence it may be worth investigating similar outer membrane proteins and lipoproteins in B. intermedia to see if they could be used as the basis for a vaccine against B.
intermedia in chickens. A mucosal route of delivery might also improve protection against colonization and lesion development in the caeca.
An unexpected observation in the current experiment was the significant reduction in antibody levels in the vaccinated chickens following experimental infection. It appeared that the serum antibody generated by vaccination was removed from the circulation during the period following infection.
Furthermore, despite the spirochaete colonizing the large intestine, there was no evidence of this boosting circulating antibody levels in the vaccinated chickens. These findings suggest the possibility that some form of immunological tolerance to B. intermedia developed as a result of vaccination.
Although the control chickens did not receive the vaccine adjuvant, it seems unlikely that it would have been responsible for these results. Overall the current observations need further investigation, and should be taken into consideration when developing vaccines against B. intermedia in chickens. 
